Biotia is advancing infectious disease diagnostics for challenging and chronic infections through pathogen genomics and artificial intelligence. As a spinout company of the Jacobs Technion-Cornell Institute at Cornell Tech, Biotia is based in New York City, where it operates a high-complexity, CLIA-certified diagnostic laboratory. Biotia's partners and collaborators include leading institutions such as Mayo Clinic, Hospital for Special Surgery (HSS), and NASA. Biotia develops cutting-edge diagnostic and software solutions to help patients, providers, and health systems identify and respond to infectious disease threats. Its flagship diagnostic test for recurrent, complicated UTIs, the BIOTIA-ID Urine Test (sensitivity 97% and specificity 99%), is available across all 50 U.S. states.

Key Contact